Salvaging Detection of Early-Stage Ovarian Malignancies When CA125 Is Not Informative

Background: Ovarian cancer is the deadliest gynecologic cancer, with no recommended screening test to assist with early detection. Cancer antigen 125 (CA125) is a serum biomarker commonly used by clinicians to assess preoperative cancer risk, but it underperforms in premenopausal women, early-stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunton, Charles J., Hutchcraft, Megan L., Bullock, Rowan G., Northrop, Lesley E., Ueland, Frederick R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394730/
https://www.ncbi.nlm.nih.gov/pubmed/34441373
http://dx.doi.org/10.3390/diagnostics11081440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394730/
https://www.ncbi.nlm.nih.gov/pubmed/34441373
http://dx.doi.org/10.3390/diagnostics11081440

Ejemplares similares